Endogenous cGMP-dependent protein kinase reverses EGF-induced MAPK/ERK signal transduction through phosphorylation of VASP at Ser239

Oncology Letters

Volumn 4, Issue 5, 2012, Pages 1104-1108

  Tao, Yan ^a   Gu, Yin Jie ^b   Cao, Zhi Hong ^b   Bian, Xiu Juan ^b   Lan, Ting ^a   Sang, Jian Rong ^a   Jiang, Lu ^a   Wang, Ying ^a   Qian, Hai ^a   Chen, Yong Chang ^a  

^a JIANGSU UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

CGMP dependent protein kinase; Endogenous; MAPK ERK; Small cell lung carcinoma; VASP

Indexed keywords

CYCLIC GMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; SERINE; SOS PROTEIN; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; POINT MUTATION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84866094136     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.851     Document Type: Article

References (31)

1. Wells A: EGF receptor. Int J Biochem Cell Biol 31: 637-643, 1999.
2. Wheeler DL, Dunn EF and Harari PM: Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nat Rev Clin Oncol 7: 493-507, 2010.
3. Hackel PO, Zwick E, Prenzel N and Ullrich A: Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol 11: 184-189, 1999.
4. Jiang H, Grenley MO, Bravo MJ, Blumhagen RZ and Edgar BA: EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila. Cell Stem Cell 8: 84-95, 2011.
5. Yamazaki T, Zaal K, Hailey D, Presley J, Lippincott-SchwartzJ and Samelson LE: Role of Grb2 in EGF-stimulated EGFR internalization. J Cell Sci 115: 1791-1802, 2002.
6. Downward J: Cell cycle: routine role for Ras. Curr Biol 7: 258-260, 1997.
7. Kolch W: Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. BiochemJ2: 289-305, 2000.
8. Stockand JD and Meszaros JG: Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol 284: H176-H184, 2003.
9. Martindale JL and Holbrook NJ: Cellular response to oxidative stress: signaling for suicide and survival. J Cell Physiol 192: 1-15, 2002.
10. Orstavik S, Natarajan V, Taskén K, Jahnsen T and Sandberg M: Characterization of the human gene encoding the type Ialpha and type Ibeta cGMP-dependent protein kinase (PRKG1). Genomics 42: 311-318, 1997.
11. Markert T, Vaandrager AB, Gambaryan S, Pöhler D, HäuslerC, Walter U, De Jonge HR, Jarchau T and Lohmann SM: Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator. J Clin Invest 96: 822-830, 1995.
12. Haslam RJ, Dickinson NT and Jang EK: Cyclic nucleotides and phosphodiesterases in platelets. Thromb Haemost 82: 412-423, 1999.
13. Schlossmann J, Ammendola A, Ashman K, Zong X, HuberA, Neubauer G, Wang GX, Allescher HD, Korth M, Wilm M, Hofmann F and Ruth P: Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 404: 197-201, 2000.
14. Ammendola A, Geiselhöringer A, Hofmann F and SchlossmannJ: Molecular determinants of the interaction between the inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate (IRAG) and cGMP kinase Ibeta. J Biol Chem 276: 24153-24159, 2001.
15. Russo I, Doronzo G, De Salve A, Mattiello L, Trovati M and Anfossi G: The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents. Thromb Res 114: 265-273, 2004.
16. Swartling FJ, Ferletta M, Kastemar M, Weiss WA and Westermark B: Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 28: 3121-3131, 2009.
17. Chen YC, Ren F, Sang JR, Tao Y and Xu WX: Type II cGMP-dependent protein kinase inhibits proliferation of the gastric cancer cell line BGC-823. Mol Med Report 3: 361-366, 2010.
18. Wu Y, Chen YC, Qu R, Lan T and Sang JR: Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells. Oncol Rep 27: 553-558, 2012.
19. Geese M, Loureiro JJ, Bear JE, Wehland J, Gertler FB and SechiAS: Contribution of Ena/VASP proteins to intracellular motility of listeria requires phosphorylation and proline-rich core but not F-actin binding or multimerization. Mol Biol Cell13: 2383-2396, 2002.
20. Lois C, Hong EJ, Pease S, Brown EJ and Baltimore D: Germline transmission and tissue-specific expression of transgenes delivered by lentiviralvectors. Science 295: 868-872, 2002.
21. Zhang XY, La Russa VF and Reiser J: Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol 78: 1219-1229, 2004.
22. de Rooij J and Bos JL: Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. Oncogene14: 623-625, 1997.
23. Draijer R, Vaandrager AB, Nolte C, de Jonge HR, Walter U and van Hinsbergh VW: Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin. Circ Res 77: 897-905, 1995.
24. Butt E, Abel K, Krieger M, Palm D, Hoppe V, Hoppe J and WalterU: cAMP-and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets. J Biol Chem 269: 14509-14517, 1994.
25. Gertler FB, Niebuhr K, Reinhard M, Wehland J and Soriano P: Mena, a relative of VASP and Drosophila Enabled, is implicated in the control of microfilament dynamics. Cell 87: 227-239, 1996.
26. Lambrechts A, Kwiatkowski AV, Lanier LM, Bear JE, Vandekerckhove J, Ampe C and Gertler FB: cAMP-dependent protein kinase phosphorylation of EVL, a Mena/VASP relative, regulates its interaction with actin and SH3 domains. J Biol Chem 275: 36143-36151, 2000.
27. Li S, Couvillon AD, Brasher BB and Van Etten RA: Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling. EMBO J 20: 6793-6804, 2001.
28. Rodrigues GA, Falasca M, Zhang Z, Ong SH and Schlessinger J: A novel positive feedback loop mediated by the docking protein Gab1 and phosphatidylinositol 3-kinase in epidermal growth factor receptor signaling. Mol Cell Biol 20: 1448-1459, 2000.
29. Schlossmann J, Feil R and Hofmann F: Insights into cGMP signalling derived from cGMP kinase knockout mice. Front Biosci 10: 1279-1289, 2005.
30. Cook AL and Haynes JM: Protein kinase G II-mediated proliferative effects in human cultured prostatic stromal cells. Cell Signal 16: 253-261, 2004.
31. Cook AL and Haynes JM: Phosphorylation of the PKG substrate, vasodilator-stimulated phosphoprotein (VASP), in human cultured prostatic stromal cells. Nitric Oxide 16: 10-17, 2007.